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Here we determined the role of various genomic islands in E. coli K1 interactions with phagocytic A. castellanii and nonphagocytic
brain microvascular endothelial cells. The findings revealed that the genomic islands deletion mutants of RS218 related to toxins
(peptide toxin, 𝛼-hemolysin), adhesins (P fimbriae, F17-like fimbriae, nonfimbrial adhesins, Hek, and hemagglutinin), protein
secretion system (T1SS for hemolysin), invasins (IbeA, CNF1), metabolism (D-serine catabolism, dihydroxyacetone, glycerol, and
glyoxylatemetabolism) showed reduced interactionswith bothA. castellanii and brainmicrovascular endothelial cells. Interestingly,
the deletion of RS218-derived genomic island 21 containing adhesins (P fimbriae, F17-like fimbriae, nonfimbrial adhesins, Hek, and
hemagglutinin), protein secretion system (T1SS for hemolysin), invasins (CNF1), metabolism (D-serine catabolism) abolished E.
coli K1-mediated HBMEC cytotoxicity in a CNF1-independent manner. Therefore, the characterization of these genomic islands
should reveal mechanisms of evolutionary gain for E. coli K1 pathogenicity.
1. Introduction
The incidence of bacterial meningitis has increased in recent
years, despite improvement in the antimicrobial chemother-
apy. Escherichia coli is the second leading cause of bacte-
rial meningitis, behind group B streptococcus (GBS), and
contributes significantly to morbidity and mortality [1–5].
The pathogenesis of E. coli meningitis involves a series of
steps: (i) bacterial entry of the intestinal tract, following
accumulation from themother’s flora during delivery or from
the environment, but this may also occur via the urinary tract
(20% of cases), or in utero following maternal bacteraemia,
(ii) bacterial colonization of the mucosa and invasion of the
intravascular space, (iii) survival and multiplication in the
bloodstream resulting in bacteraemia, (iv) bacterial crossing
of the blood-brain barrier and invasion of the central nervous
system resulting in inflammation, pleocytosis, and neuronal
injury that ultimately leads to death; however, there are a few
survivors with neurological sequelae [2, 6–9]. Each of the
aforementioned steps is highly complex that requires specific
pathogen-host interactions involving a plethora of molecules
associated with different stages of meningitis development.
For example, E. coli crossing of the brain microvascular
endothelial cells (BMEC) that constitute the blood-brain
barrier can be divided into four steps: (i) E. coli binding to
the BMEC using a variety of adhesins, (ii) E. coli invading
the BMEC using a variety of invasins, (iii) E. coli-containing
vacuole intracellular trafficking across the cell, that is, from
the apical side to the basolateral side, and (iv) E. coli exiting
on the central nervous system side [7]. Evolutionarily, it is not
clear how E. coli has developed such a sophisticated mecha-
nism(s) resulting in virulence to produce human and animal
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infection. In this regard, amoebae have been suggested as the
“training ground” during evolution of intracellular bacterial
pathogens [10]. Thus, it is hypothesized that the fragility of
non-spore-forming bacteria to survive hostile conditions and
inability to disperse to favorable environments may have led
to their evolutionary need to associate with a hardy host
and/or a biological reservoir such asAcanthamoeba to remain
viable intracellularly in the face of harsh conditions, whereas
bacteria use Acanthamoeba to enhance their pathogenicity.
In such harsh environmental conditions, it is plausible that
Acanthamoeba harbor bacteria and transmit them to the
susceptible hosts.Once in the gut, amoebaemay lyse resulting
in bacterial colonization. Thus it is important to under-
stand interactions of pathogenic bacteria withAcanthamoeba
that may have influenced evolutionary gain of E. coli K1
pathogenicity and their potential role in the transmission.
Research over the last few decades has identified bac-
terial virulence determinants that are associated with E.
coli K1 meningitis including fimbrial protein, FimH, outer
membrane protein A (OmpA), cytotoxic necrotizing factor
1 (Cnf-1), Ibe proteins, AslA and TraJ, and the K1 capsular
polysaccharide [7, 11]. The E. coli K1 genome has been
sequenced (http://www.genome.wisc.edu) and 22 genomic
islands consisting of ∼793 kb have been identified that are
present in meningitis-causing E. coli RS218 but absent in the
nonpathogenic E. coli MG1655 [12]. Thus it is reasonable to
suspect the presence of several additional virulence determi-
nants involved in neuropathogenic E. coliK1 pathogenesis. In
the present study, we determined the role of various genomic
islands in E. coli K1 interactions with an environmental
phagocyte, Acanthamoeba castellanii, and nonphagocytic
brain endothelial cells.
2. Methods
A clinical isolate of A. castellanii belonging to T4 genotype,
originally isolated from a keratitis patient (American Type
Culture Collection, ATCC 50492) was used in the present
study.A. castellaniiwas cultured in the PYGmedium contain-
ing (0.75% (w/v) proteose peptone, 0.75% (w/v) yeast extract
and 1.5% (w/v) glucose)) [13].
E. coli K1 strain E44, used in the present study, is
a rifampicin-resistant mutant of strain RS218 (serotype
O18:K1:H7). This strain is a clinical isolate from the cere-
brospinal fluid of a neonate with meningitis. A series of
seventeen strains of E. coli RS218-derived genomic islands
(RDIs), using a comparative genome analysis of meningitis-
causing E. coli K1 strain RS218 (O18:K1:H7), together with a
plasmid-cured E. coliK1 strain RS218 were obtained from the
laboratory of Kwang S. Kim (Johns Hopkins University) as
previously described [12, 14, 15] (Figure 1 and Table 1). To this
end, a 20 kb K-12 specific DNA (genomic deletion in K1) was
inserted into K1 genome using P1 transduction. Briefly, island
boundaries were identified using genetic mapping, followed
by insertion of antibiotic tag in the corresponding region
of either K1 strain E44 or K-12 strain MG1655 using 𝜆Red
recombinase. P1 𝜙 transduction from MG1655 to E. coli K1
Table 1: Summary of E. coliK1 RS218 derived islands (RDI’s) and its
genomic islands mutants tested in the present study.
E. coli K1
Identity Function and potential virulence factor







Strain, in which genomic deletion (black
hole) observed in RS218 was filled with
respective DNA from HB101
RDI 1 Invasins (IcmF and IcmH).
RDI 2 Prophage genes.
RDI 4
Adhesins (S fimbriae, antigen 43). Protein
secretion system (T5SS for antigen 43). Iron
uptake system (Iro system and hmu system).
RDI 9 Iron uptake system (Ybt system).
RDI 10 Toxins (peptide toxin).
RDI 12
Other virulence factors (sia operon).
Prophage genes.
RDI 14 Prophage genes.
RDI 15 Metabolism (sugar metabolism).
RDI 16
Protein secretion system (T2SS).Other
virulence factors (K1 capsule biosynthesis).
RDI 17 Metabolism (phosphor-sugar metabolism).
RDI 18 Prophage genes.
RDI 21
Adhesins (P fimbriae, F17-like fimbriae,
non-fimbrial adhesins, Hek and
hemagglutinin). Protein secretion system
(T1SS for hemolysin). Invasins (CNF1).
Metabolism (D-serine catabolism).
RDI 22
Invasins (IbeA). Toxins (𝛼-hemolysin).
Metabolism (dihydroxyacetone, glycerol,
and glyoxylate metabolism).
results in the deletion of K1-specific genes, replaced with K-
12 genes (Figure 1 andTable 1) as previously described [12, 14].
All bacterial strains were aerobically grown for approximately
14 h in Luria-Bertani (LB) broth at 37∘C.
Primary brain microvascular endothelial cells (BMEC)
were isolated from seizure patient who had undergone cere-
bral cortex resection as previously described [16].TheBMECs
were grown in T-75 tissue culture flasks in RPMI-1640
containing 10% heat inactivated fetal bovine serum, 10% Nu-
serum, 2mM glutamine, 1mMNa-pyruvate, 100U/mL peni-
cillin, 100 𝜇g/mL streptomycin, nonessential amino acids,
and vitamins as previously described [16, 17].
For cytotoxicity assays, 1 × 105 BMECs per well per
0.5mL were cultured in 24-well plates and incubated at
37∘C in a 5% CO
2
. Under these conditions, BMECs formed
complete monolayers within 48 h. E. coliK1 and its derivative
mutants were grown in LB for overnight and the optical
density was adjusted to 0.22 absorbance at wavelength of




























Figure 1: Comparative genomes of E. coli K1 and E. coli K-12. Common DNA: large circle represents the common E. coli backbone. K1-
specific elements: 22 (numbered) islands of K1-specific DNA are represented as smaller circles and a plasmid. K-12-specific elements: 20 kb
K-12 specific DNA is indicated in grey (referred to as a “black hole” in K1 genome). Adopted from Xie et al. [12].
595 nm (equivalent to approximately 108 colony forming
units (c.f.u.) per mL) [15]. Next, 10 𝜇L containing 106 c.f.u.
were transferred to 490 𝜇L RPMI 1640, supplemented with
10% heat-inactivated fetal bovine serum, and inoculated in
each well of a 24-well plate containing BMEC monolayers.
Plates were incubated at 37∘C in a 5% CO
2
incubator and
monitored for monolayer disruptions over the period of
24 h. Next, the supernatants were collected and centrifuged
at 12000×g for 5min to remove cellular debris. Cytotoxic
effects were determined by estimating the release of cytosolic
lactate dehydrogenase release in the medium (Cytotoxicity
Detection kit; Roche Applied Sciences). The percent cyto-
toxicity was calculated as follows: % cytotoxicity = (sample
value−control value)/(total LDH release−control value) ×
100. Control values were obtained by incubating BMEC
monolayers with 500𝜇LRPMI-1640 alone and total LDHwas
released from BMEC by completely lysing them in 500 𝜇L 1%
Triton X-100.
Assays were performed to determine E. coli K1 and its
derivative mutant association with A. castellanii and human
BMEC. For A. castellanii, amoebae were maintained in the
trophozoite stage in tissue culture flasks in the PYGmedium.
Upon confluency, the unbound amoebae were aspirated and
growing trophozoites were rinsed with phosphate buffer
saline (PBS) pH 7.4. Next, 5mL of PYG medium was added
to the flask and trophozoites were chilled on ice for 20min
and pelleted by centrifugation at 900×g for 5min. The cell
pellet was resuspended in 1mL of PBS and the number of
amoebae was counted using a haemocytometer. E. coli K1
and its derivative mutants (107 c.f.u.) were incubated with A.
castellanii (106 cells) at 30∘C for 1 h. Following 1 h of incu-
bation, amoebae were centrifuged at 2000×g for 5min. The
supernatants were aspirated and pellet resuspended in 0.5mL
of PBS.This process was repeated 3× to remove nonadherent
bacteria.The amoebaewere counted using a haemocytometer
and then lysed by adding SDS (0.5% final concentration) for
10min at room temperature, which does not affect E. coli
viability [18]. The lysates containing bacteria were plated on
nutrient agar plates and colonies enumerated the next day
[18]. The bacterial colony forming units associated with A.
castellanii were calculated as follows: (number of bacterial
c.f.u./number of amoebae) × 100 = bacterial association of
A. castellanii (percentage). To study E. coli interactions with
human cells, BMECs were grown to confluent monolayers in
24-well plates. Next, E. coliK1 and its derivative mutants were
incubated with human BMEC (107 c.f.u. per well in 0.5mL)
and plates were incubated at 37∘C in 5%CO
2
incubator. After
60min of incubation, the monolayers were washed with PBS
and BMECs were lysed by adding 500 𝜇L of distilled water for
30min together with gentle scraping of the well. The lysate
was plated on nutrient agar and the colonies were counted
the next day. The bacterial colony forming units associated
with BMEC for the wild type E. coli K1 was arbitrarily set at
100% and the results of the mutants strains are expressed as
the relative change.
Assays were performed to determine E. coli K1 and
its derivative mutant uptake/invasion by A. castellanii and
human BMEC. Briefly, amoebae were incubated with E. coli
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and its derivative mutants as described for association assays.
After washing for 3×, the extracellular bacteria were killed by
adding gentamicin (100 𝜇g per mL in PBS for 60min. Finally,
amoebae and bacteria were enumerated as described above.
The bacterial colony forming units invading A. castellanii
were calculated as follows: (number of bacterial c.f.u./number
of amoebae) × 100 = bacterial invasion of A. castellanii.
For human BMEC, E. coli K1 and its derivative mutants
were incubated with BMEC. After 60min of incubation,
the monolayers were washed with PBS and incubated with
gentamicin (100 𝜇g per mL in RPMI-1640) for 60min to
kill extracellular bacteria. The wells were then washed twice
with RPMI-1640 and bacterial colony forming units were
determined as described above.
Assays were performed to determine E. coli K1 and
its derivative mutant intracellular survival of A. castellanii
and human BMEC. Briefly, following invasion assays, A.
castellanii was washed 3× with PBS and incubated in 0.5mL
of PBS for 24 h at 30∘C. Finally, amoebae and bacteria were
enumerated. The bacterial colony forming units surviving
inside A. castellanii were calculated as follows: (number of
bacterial c.f.u./number of amoebae)× 100 = bacterial survival
of A. castellanii. For human BMEC, following invasion assay,
the monolayers were washed twice with RPMI-1640 and
BMECs were incubated in 0.5mL of RPMI-1640 for 4 h at
37∘C in a 5%CO
2
incubator. Finally, bacterial colony forming
units were determined.
Encystment assays were performed to evaluate the ability
of E. coli K1 and its derivative mutants to survive inside A.
castellanii cysts. In brief, following invasion assays, the mix-
tures were transferred onto nonnutrient agar plates (prepared
using 3% (w/v) purified agar). The plates were incubated at
room temperature for up to 10 days. This allowed a complete
encystment ofA. castellanii trophozoites into the cyst form, as
observed visually under a phase-contrast microscope. Cysts
were then gently scraped off the agar surface using a cell
scraper by adding 5mL of dH
2
O and collected by centrifu-
gation at 2000×g for 10min and resuspended in 0.5mL of
dH
2
O and counted using a haemocytometer. The cysts were
treated with SDS (0.5% final concentration) and the bacterial
colony forming units were determined by plating on nutrient
agar plates. The bacterial colony forming units surviving
intracellular of A. castellanii cysts were calculated as follows:
(number of bacterial c.f.u./number of amoebae cysts) × 100 =
bacterial survival ofA. castellanii cysts. Statistical significance
for differences was evaluated using Student’s t-test in Excel. A
critical value of𝑃 < 0.05was used for all analysis using paired
t-test, one-tailed distribution. Data are presented as themean
± standard error.
3. Results
Plasmids, bacteriophages, and pathogenicity islands are
genomic additions that contribute to the evolution of bacte-
rial pathogens. In addition to acquired virulence genes on a
plasmid, chromosomal genes are also lost via deletions. The
formation of these “black holes,” that is, deletions of genes
that are detrimental to a pathogenic lifestyle, provides an
evolutionary pathway that enables a pathogen to enhance
virulence [14]. For E. coli interactions with A. castellanii, the
findings revealed that the deletion of RDIs 2, 9, 10, 15, and
17 resulted in significantly reduced association, while RDI
21 exhibited increased association with A. castellanii (𝑃 <
0.05 using paired t-test, one-tailed distribution) (Table 2).
For invasion of A. castellanii, plasmid cured RS218, the wild
type E. coli K1 in which black hole (region of genomic
deletion in K1 but present in K-12) was filled with K-12
HB101 DNA, deletions of RDIs 2, 9, 10, 12, 15, 18, 21, and
22 caused significantly reduced invasion of A. castellanii
compared with the wild type E. coli K1 (𝑃 < 0.05) (Table 2),
while the deletion of RDI 4 resulted in increased invasion.
In survival assays, plasmid cured RS218, deletions of RDIs 9,
10, 18, 21, and 22 lead to significantly reduced survival of A.
castellanii compared with the wild type E. coli K1 (𝑃 < 0.05)
(Table 2), while A. castellanii remained intact and viable after
survival prior to lysing with the SDS. When tested for their
ability to survive transformation of A. castellanii trophozoite
into cyst forms, the findings revealed that plasmid cured
RS218, deletions of RDIs 2, 4, 9, 10, 16, 18, 21, and 22
caused significantly reduced recovery fromA. castellanii cysts
comparedwith thewild type E. coliK1 (𝑃 < 0.05) (Table 2). In
contrast, the wild type E. coliK1 in which black hole was filled
with K-12 HB101 DNA and the deletion of RDI 17 showed
increased recovery from A. castellanii cysts compared with
the wild type E. coli K1 (𝑃 < 0.05) (Table 2).
For E. coli interactions with BMEC, the plasmid cured
RS218, the wild type E. coli K1 in which black hole was filled
with K-12 HB101 DNA and deletions of RDIs 10, 12, 15, 16,
21, and 22 resulted in significantly reduced association with
BMEC (𝑃 < 0.05) (Table 3). For invasion of BMEC, plasmid
cured RS218, the wild type E. coli K1 in which black hole was
filled with K-12 HB101 DNA and deletions of RDIs 2, 10, 17,
21, and 22 lead to significantly reduced invasion of BMEC
compared with the wild type E. coli K1 (𝑃 < 0.05) (Table 2),
while the deletion of RDI 18 showed increased invasion. In
survival assays, plasmid cured RS218, deletions of RDIs 10, 17,
21, and 22 caused significantly reduced survival inside BMEC
comparedwith thewild type E. coliK1 (𝑃 < 0.05) (Table 2). In
contrast, the wild type E. coliK1 in which black hole was filled
with K-12 HB101 DNA and the deletion of RDI 16 showed
increased recovery from A. castellanii cysts compared with
the wild type E. coli K1 (𝑃 < 0.05) (Table 2).
For BMEC cytotoxicity, all mutants tested except RDI
21 showed BMEC death at levels similar to the wild type E.
coli K1 RS218. The wild type E. coli K1 RS218 lacking RDI
21 showed significantly reduced levels of BMEC cytotoxicity
(𝑃 < 0.05) (Table 3). Among other virulence factors encoded
by the genomic island, previously our studies have identified
cytotoxic necrotizing factor-1 (CNF-1) as an important toxin
encoded by this genomic island that is required for E. coli
K1 invasion of BMEC in vitro and demonstrated its role
in producing meningitis in newborn rats in vivo [15]. To
determine whether abrogation of cytotoxicity in RDI 21 is
due to cnf1 deletion, we used isogenic cnf1 mutant tested in
cytotoxicity assays. The results revealed that Δcnf1 produced
BMEC death at levels similar to the wild type E. coliK1 RS218
(Figure 2) suggesting that RDI 21 gene(s)/factors other than
BioMed Research International 5
Table 2: RS218-derived islands (RDI’s)mutants and their interactionswithAcanthamoeba castellanii.Thenumber ofE. coliK1 c.f.u. interacting
with A. castellanii was considered as 100% and the results of mutants strains are expressed as the relative change.
Identity A. castellanii
Association Invasion Survival Cyst survival
K1 (RS218) 100 100 100 100
Plasmid cured RS218 130.49 ± 25 26.19 ± 2∗ 75.19 ± 10∗ 25 ± 5∗
RS218 in which black hole was filled
with respective DNA from HB101 143.8 ± 19 32.74 ± 7
∗ 147.84 ± 23 227.5 ± 23∗
RDI 1 111 ± 12 96.42 ± 9 132.8 ± 14 93.75 ± 16
RDI 2 68.53 ± 7∗ 36.90 ± 3∗ 132.8 ± 11 63.75 ± 8∗
RDI 4 246.53 ± 31 143.44 ± 20∗ 108.58 ± 15 55 ± 5∗
RDI 9 52 ± 3∗ 76.19 ± 6∗ 65 ± 8∗ 10 ± 2∗
RDI 10 45.9 ± 6∗ 51.78 ± 5∗ 63.66 ± 6∗ 8.75 ± 3∗
RDI 12 83.62 ± 10 69 ± 11∗ 92.18 ± 10 158.75 ± 9
RDI 14 88.92 ± 15 81.54 ± 11 97.26 ± 9 165 ± 5
RDI 15 60.19 ± 8∗ 73.8 ± 12∗ 110.34 ± 18 136.25 ± 13
RDI 16 124.7 ± 18 116 ± 11 93.35 ± 7 60 ± 9∗
RDI 17 49.95 ± 6∗ 83.92 ± 9 108.39 ± 16 172.5 ± 12∗
RDI 18 117.97 ± 16 28.57 ± 2∗ 25.38 ± 3∗ 8.12 ± 1∗
RDI 21 157 ± 14∗ 39.28 ± 4∗ 70.89 ± 6∗ 45 ± 3∗
RDI 22 109.62 ± 9 38.69 ± 6∗ 9.76 ± 1∗ 16.25 ± 3∗
(i) Association was calculated as follows: (number of bacterial c.f.u./number of amoebae) × 100 = bacterial association of A. castellanii.
(ii) Invasion was calculated as follows: (number of bacterial c.f.u./number of amoebae) × 100 = bacterial invasion of A. castellanii.
(iii) Survival was calculated as follows: (number of bacterial c.f.u./number of amoebae) × 100 = bacterial survival of A. castellanii.
(iv) Cyst survival was calculated as follows: (number of bacterial c.f.u./number of amoebae cysts) × 100 = bacterial survival of A. castellanii cysts.
∗indicates a significant difference (P < 0.05 using paired t-test, one-tailed distribution) when data of mutant strains were compared with the wild type E. coli
K1 data.
Table 3: RS218-derived islands (RDI’s) mutants and their interactions with human brain microvascular endothelial cells (HBMEC). For
associated, invasion, and survival assays, the number of E. coli K1 c.f.u. interacting with HBMEC was considered as 100% and the results of
mutant strains are expressed as the relative change. For cytotoxicity assays, E. coli K1-mediated HBMEC death was considered as 100% and
the results of mutant strains are expressed as the relative change.
E. coli HBMEC
Association Invasion Survival Cytotoxicity
K1 (RS218) 100 100 100 100
Plasmid cured RS218 27.41 ± 4.5∗ 92.52 ± 5.6∗ 70.86 ± 6∗ 104 ± 7.8
Black hole filled with HB101 DNA 31 ± 1.6∗ 62.86 ± 13∗ 163.5 ± 28∗ 87 ± 10
RDI 1 89.97 ± 1.2 112.8 ± 10.6 96.56 ± 8 97 ± 13
RDI 2 98.42 ± 2.6 72.5 ± 8.7∗ 91.6 ± 9.1 108 ± 14
RDI 4 93.6 ± 3.52 98.37 ± 0.8 96.76 ± 1.8 124 ± 2.3
RDI 9 101.47 ± 2.6 109.6 ± 4.4 106.5 ± 3.4 110 ± 12
RDI 10 61.12 ± 1.4∗ 58.5 ± 6.1∗ 55.47 ± 6∗ 92.8 ± 3
RDI 12 70.7 ± 8.3∗ 88.3 ± 7.1 107.5 ± 11 89.9 ± 9
RDI 14 105.84 ± 4.1 133.7 ± 22 96.7 ± 11 103 ± 4
RDI 15 53.97 ± 7.5∗ 115.9 ± 5.5 113.6 ± 3.1 118 ± 7
RDI 16 67.78 ± 3∗ 111 ± 13 156.1 ± 19∗ 127 ± 5.4
RDI 17 104 ± 1 69.77 ± 7.4∗ 60.4 ± 3.4∗ 105 ± 2
RDI 18 107.52 ± 1.6 159.2 ± 18∗ 108.6 ± 8.8 88 ± 1.8
RDI 21 32.82 ± 4.6∗ 25 ± 3.6∗ 17.95 ± 3∗ 14.5 ± 1.1∗
RDI 22 77.9 ± 8.9∗ 61.53 ± 8∗ 50.45 ± 7∗ 127 ± 3.4
(i) Association was calculated as follows: (number of bacterial c.f.u. recovered/original inoculum) × 100 = bacterial association of HBMEC.
(ii) Invasion was calculated as follows: (number of bacterial c.f.u. recovered/original inoculum) × 100 = bacterial invasion of HBMEC.
(iii) Survival was calculated as follows: (number of bacterial c.f.u. recovered/original inoculum) × 100 = bacterial survival of HBMEC.
(iv) Cytotoxicity was calculated as follows: (sample value − negative control value)/(total LDH release − negative control value) × 100 = HBMEC cytoxicity.
∗indicates a significant difference (P < 0.05 using paired t-test, one-tailed distribution) when data of mutant strains were compared with the wild type E. coli
K1 data.




















E. coli K1 RDI 21 Δcnf1
Figure 2: Escherichia coli K1-mediated human brain microvascular
endothelial cell cytotoxicity was abolished with the deletion of
RS218-derived genomic island 21. E. coliK1 strain E44 (106 c.f.u.) was
added to confluent cultures of primary human brain microvascular
endothelial cells (HBMEC) grown in 24-well plates. Plates were
incubated in a CO
2
incubator for 24 h. At the end of the incubation,
supernatants were tested for LDH release and converted to percent-
age cell death as described in Section 2. Data represent the mean
± standard error of three independent experiments. Note that the
deletion of RS218-derived genomic island 21 (RDI 21) abolished E.
coli K1-mediated cytotoxicity.
CNF-1 are involved in E. coli K1-mediated cytotoxicity of
BMEC.
4. Discussion
Acanthamoeba is a Trojan horse of the microbial world.
It acts as reservoir for many bacterial pathogens such as
Legionella pneumophila, Pseudomonas aeruginosa, Coxiella
burnetii, Vibrio cholera, and many others [19]. These bac-
terial pathogens survive and multiply inside Acanthamoeba
under harsh environmental conditions and are transmitted
to susceptible hosts. For instance, residing within amoeba has
been suggested as the “training ground” during evolution of
bacteria to become human pathogens [10, 20]. The evolution
of one species to house inside another is a remarkable
adaptation and consistent with the fundamental principle
of natural selection to favour cooperation. In a landmark
observation of Rowbotham [21], it was shown that Legionella
pneumophila can survive intracellular of Acanthamoeba. The
ability of L. pneumophila to resist grazing by Acanthamoeba
suggested their long coevolutionary history combined with
a series of adjustments ensuring bacterial survival and that
grazing resistance may have influenced evolutionary gain
of bacterial pathogenicity [20, 22]. Thus it is important to
study interactions of bacteria that are human pathogens
with the environmental Acanthamoeba to identify potential
virulence determinants. Previous studies have shown that
RDIs 12 (sia operon; prophage genes) and 22 (invasins (IbeA);
toxins (alpha-hemolysin), metabolism) are crucial in E. coli
K1 RS218 association with BMEC [12]. In contrast, our
findings revealed that deletion of neither RDI 12 nor 22 had
any effect on the wild type E. coli K1 association with A.
castellanii keratitis isolate belonging to the T4 genotype. A
likely explanation may be that E. coli K1 association with a
nonphagocytic BMEC is driven by bacterial determinants.
Thus the deletion of the genomic island containing adhesins
would result in reduced association as observed by Xie et
al., 2006 [12]. However, phagocytic nature of Acanthamoeba
would result in bacterial uptake mediated by host amoeba,
in addition to the presence of specific bacterial adhesins.
Notably, when tested for their association with BMEC, both
RDIs 12 and 22 showed significantly reduced levels of BMEC
association which is consistent with previous findings of Xie
et al. [12]. The ability of E. coli to survive within A. castellanii
trophozoite stage as well as withstand transformation of
the trophozoite form into the cyst form is a remarkable
property. We believe that the genomic islands required for
this process are of particular interest in our search for
potential E. coli K1 virulence determinants. It was interesting
to note that strains including plasmid cured RS218, the
wild type E. coli K1 in which black hole was filled with K-
12 HB101 DNA, RDIs 2 (prophage genes), 4 [adhesins (S
fimbriae, antigen 43), protein secretion system (T5SS), iron
uptake system], 9 (iron uptake system), 10 [toxins (peptide
toxins)], 16 [protein secretion system (T2SS), K1 capsule
biosynthesis], 18 (prophage genes), 21 [adhesins (P fimbriae,
nonfimbrial adhesins), protein secretion system (T1SS)], and
22 [invasins (IbeA); toxins (alpha-hemolysin), metabolism]
showed recovery from cysts at reduced levels compared
with the wild type E. coli K1 RS218. Our previous findings
revealed that type III secretion system (within the RDI 7)
and neuDB genes cluster (within the RDI 16) is important
for E. coli K1 interactions with A. castellanii [23, 24]. While
being consistent with previous data, RDI 16 showed reduced
recovery of E. coli K1 from cysts; however, there is a need to
determine the role of RDI 7 in E. coli K1 interactions with A.
castellanii as well as HBMEC and this will be addressed in
future studies.
For BMEC, the results revealed that the deletion of
RDIs 10 [toxins (peptide toxins)], 21 [adhesins (P fimbriae,
nonfimbrial adhesins), protein secretion system (T1SS)], and
22 [invasins (IbeA); toxins (alpha-hemolysin), metabolism]
reduced the ability of E. coli K1 to associate, invade, and
survive BMEC. When comparing with the intracellular cyst
survival assays, three RDIs, 10, 21, and 22, were important in
their interactions with both BMEC as well as A. castellanii.
Future studies are needed to precisely determine the role of
specific virulence determinant(s) within each genomic island
required for E. coli K1 interactions with A. castellanii and
BMEC.
Consistent with previous findings [12], it was observed
that RDI 12 deletion resulted in reduced E. coliK1 association
with BMEC but had no effect on its invasion of BMEC.
Similarly, it was observed that RDI 22 deletion resulted in
reduced E. coli K1 invasion of BMEC but had no effect on
its association of BMEC. In contrast, RDI 1 deletion affected
neither association nor invasion of BMEC,while Xie et al. [12]
showed reduced levels of invasion.This could be due to assay
conditions such as 90min [12] versus 60min incubations
in our assays. Given that assays are performed under static
conditions in the absence of any immune factors, compared
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with the in vivo situation and under dynamic blood flow, it is
believed that 60min incubations provide ample opportunity
for bacteria to interact with the host cells. Additionally,
a reduced duration of incubation will limit the effects of
extracellular factors that are shed during bacterial growth
(e.g., LPS), as the generation time for E. coli under laboratory
conditions is 15 to 20min. Apart from this anomaly, the
findings regarding E. coli K1 interactions HBMEC observed
in this study are consistent with those observed by Xie et
al. [12] and further suggest the need to identify virulence
determinant(s) within these genomic islands.
In addition to meningitis, E. coli K1 sepsis is a serious
complication with a mortality rate of >50%. It is the result of
a high level of bacteremia and characterized by capillary leak,
hypotension, and organ dysfunction [2]. Both lipopolysac-
charide (LPS) [24] and non-LPS factors are involved in
disease pathogenesis [20]. To identify potential determinants,
variousE. coliRS218-derived genomic islands (RDIs) deletion
mutants of E. coli K1 were tested for their ability to produce
BMEC death. The deletion of RDI 21 significantly reduced
the level of BMEC death (𝑃 < 0.05) suggesting the presence
of putative virulence determinants in this genomic island. As
CNF-1 has been identified as an important toxin encoded by
this genomic island that is required for E. coli K1 meningitis
[15], it was tempting to test its role in BMEC death. Notably,
Δcnf1 exhibited BMEC death at levels similar to the wild type
E. coli K1 RS218 suggesting that RDI 21 gene(s)/factors other
than CNF-1 are involved in E. coli K1-mediated BMEC death.
This is not surprising as distinct bacterial determinants are
likely required for sepsis and the blood-brain barrier crossing
leading to meningitis. Findings observed in this study may
lead to future discovery of potential targets for therapy against
sepsis as well as to the identification of determinants required
for bacterial survival in the environmental phagocyte.
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